bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-71-3406

Order Name:
Longitudinal (PHC) - Foundation ACT, Blood **

 
Useful For:
ลดราคาสำหรับ คนไข้ที่เคยตรวจ Foundation มาก่อน

This liquid biopsy test for solid tumor that help direct therapy selection and clinical trial options for advanced-stage cancer patients using a minimally invasive sample type.

FoundationOne Liquid empowers providers to make more informed clinical decisions even when tissue is not ideal.
Analyte PD-L1 + 62 genes (DNA): Point mutations, insertions/deletions, copy number alterations, rearrangements
 
Methodology:
Next-generation sequencing (NGS)
 
AliasesName:
FoundationOne Liquid
Foundation, Liquid Biopsy
 
 
 
Test Code:
090-71-3406

Order Name:
Longitudinal (PHC) - Foundation ACT, Blood **

 
Patient Preparation:
คนไข้เคยส่งตรวจ Foundation ที่ร.พ.บำรุงราษฎร์มาก่อนเท่านั้น
 
Collection Specimen Or Container:
Blood/ Special blood collection kit (Foundation)

Document Required
Filled Requisition Form & Sign Consent of Referral Lab
 
Specimen Testing Type:
Whole blood 10 mL Streck tube, 2 tubes
 
Sub Mission Container:
Specimen collection kit
 
Rejection Criteria:
Hemolysis: N/A
Lipemia: N/A
Icterus: N/A
Other: Insufficient volume will be reject.
 
Specimen Stabillity:
Specimen Type Temperature Time
cfDNA Whole Blood Room temperature, 18oC to 25oC 7 days
 
 
 
Test Code:
090-71-3406

Order Name:
Longitudinal (PHC) - Foundation ACT, Blood **

 
Method detail:
Next-generation sequencing (NGS)
 
Schedule:
N/A **Sent Out to Foundation Medicine, USA
 
Turnaround Time:
20-30 days
 
Performing Location:
FMI, Foundation Medicine
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-71-3406

Order Name:
Longitudinal (PHC) - Foundation ACT, Blood **

 
 
Reference Value:
An interpretive report will be provided.
 
Interpretation:
Test results are provided directly to physicians in a report that highlights the genomic alterations and biomarkers present in a patient’s cancer and includes information to help inform clinical decision making. Everything in the report is supported by up-to-date clinical findings and scientific research.
 
Clinical Reference:
www.foundationmedicine.com (Retrieved: 15 Apr 2019)